antiarrhythmic effects of intravenous coronary vasodilators ( verapamil , diltiazem , bepridil , trimetazidine and nicorandil ) were evaluated using two canine ventricular arrhythmia models ( halothane-adrenaline arrhythmia and digitalis arrhythmia ) , and the minimum effective plasma concentrations of the drugs were determined for each arrhythmia model .
C0085612
ventricular arrhythmia
C0003811
arrhythmia